AQP3 and AQP9-Contrary Players in Sepsis?

Area of Science:

• Immunology
• Molecular Biology
• Pathophysiology

Background:

• Sepsis is a systemic immune response to infection, involving complex biological networks.
• Aquaporins (AQPs) are implicated in immunological processes, with AQP3 and AQP9 being of particular interest in immune cells.

Purpose of the Study:

• To investigate the expression of aquaporins 3 (AQP3) and 9 (AQP9) in blood cells of septic patients.
• To determine the correlation between AQP3 and AQP9 expression and sepsis survival.
• To evaluate AQP9 as a potential drug target and biomarker for sepsis.

Main Methods:

• Analysis of clinical data, laboratory parameters, and blood samples from septic patients at day 1 and day 8 post-diagnosis.
• Measurement of aquaporin (AQP) expression and serum cytokine concentrations.
• Correlation analysis between AQP expression, immune cell counts, and patient survival.

Main Results:

• AQP3 mRNA expression increased during sepsis and correlated with lymphocyte count; higher AQP3 levels were linked to improved survival.
• AQP9 expression remained unchanged but correlated with neutrophil count; lower AQP9 levels were associated with increased survival.
• AQP9 expression was identified as an independent risk factor for sepsis mortality.

Conclusions:

• Aquaporins AQP3 and AQP9 exhibit opposing roles in sepsis pathophysiology.
• AQP9 may serve as a novel therapeutic target and a valuable prognostic biomarker for sepsis.